Ilona Cunningham

734 total citations
14 papers, 422 citations indexed

About

Ilona Cunningham is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Ilona Cunningham has authored 14 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Ilona Cunningham's work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (2 papers) and Innovations in Medical Education (2 papers). Ilona Cunningham is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (2 papers) and Innovations in Medical Education (2 papers). Ilona Cunningham collaborates with scholars based in Australia, United States and United Kingdom. Ilona Cunningham's co-authors include Patricia M. Lyon, Les Barnsley, Emily Hibbert, Michael J. Field, Peter Y. Liu, Ross E. Brown, David J. Handelsman, Derek N.J. Hart, Pablo A. Silveira and Georgina J. Clark and has published in prestigious journals such as Blood, PLoS ONE and Medical Education.

In The Last Decade

Ilona Cunningham

13 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilona Cunningham Australia	6	205	84	77	67	63	14	422
S. Williams United Kingdom	7	171 0.8×	41 0.5×	18 0.2×	127 1.9×	107 1.7×	16	565
Marije P. Hennus Netherlands	15	120 0.6×	44 0.5×	54 0.7×	6 0.1×	59 0.9×	42	656
Susan E. Creary United States	13	61 0.3×	13 0.2×	30 0.4×	443 6.6×	67 1.1×	67	745
Rosemary Adamson United States	9	68 0.3×	12 0.1×	30 0.4×	19 0.3×	22 0.3×	30	265
Craig A. Piquette United States	10	80 0.4×	27 0.3×	104 1.4×	7 0.1×	25 0.4×	14	432
Jessica Servey United States	10	160 0.8×	36 0.4×	18 0.2×	22 0.3×	36 0.6×	27	388
Mark D. Brissette United States	12	227 1.1×	62 0.7×	29 0.4×	23 0.3×	55 0.9×	22	383
Michael J. Battistone United States	14	244 1.2×	114 1.4×	17 0.2×	43 0.6×	89 1.4×	35	492
Carlos El‐Haddad Australia	9	82 0.4×	30 0.4×	12 0.2×	23 0.3×	72 1.1×	16	272
M van Santen-Hoeufft Netherlands	7	123 0.6×	42 0.5×	26 0.3×	202 3.0×	37 0.6×	10	380

Countries citing papers authored by Ilona Cunningham

Since Specialization

Citations

This map shows the geographic impact of Ilona Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Cunningham more than expected).

Fields of papers citing papers by Ilona Cunningham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilona Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Cunningham. The network helps show where Ilona Cunningham may publish in the future.

Co-authorship network of co-authors of Ilona Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Ilona Cunningham. A scholar is included among the top collaborators of Ilona Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilona Cunningham. Ilona Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tan, Sim Yee, Jane Turner, Lorraine Hewitt, et al.. (2024). Completion Rate of Paper‐Based and Electronic Patient Reported Outcome Measures in a Multidisciplinary Cancer Survivorship Clinical Setting. Asia-Pacific Journal of Clinical Oncology. 21(3). 275–280.

Garcia‐Manero, Guillermo, Olatoyosi Odenike, Shaun Fleming, et al.. (2023). Combination of Venetoclax and Azacitidine in Patients with Treatment-Naive, High-Risk Myelodysplastic Syndromes with Responses Leading to Stem Cell Transplantation. Blood. 142(Supplement 1). 1868–1868. 3 indexed citations

Wei, Andrew H., Jacqueline S. Garcia, Uma Borate, et al.. (2021). MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results. Clinical Lymphoma Myeloma & Leukemia. 21. S343–S343. 4 indexed citations

Garcia, Jacqueline S., Andrew H. Wei, Uma Borate, et al.. (2020). Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study. Blood. 136(Supplement 1). 55–57. 36 indexed citations

Abadir, Edward, Robin Gasiorowski, Phillip D. Fromm, et al.. (2019). Examination of CD302 as a potential therapeutic target for acute myeloid leukemia. PLoS ONE. 14(5). e0216368–e0216368. 9 indexed citations

Kenealy, Melita, Mark Hertzberg, Kerry Taylor, et al.. (2018). Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia. Haematologica. 104(4). 700–709. 13 indexed citations

Trotman, Judith, Yiu Lam Kwan, Jane Estell, et al.. (2016). Formalising multidisciplinary peer review: developing a haematological malignancy‐specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence‐based clinical practice. Internal Medicine Journal. 47(5). 542–548. 5 indexed citations

Bryant, Christian, Phillip D. Fromm, Fiona Kupresanin, et al.. (2016). A CD2 high‐expressing stress‐resistant human plasmacytoid dendritic‐cell subset. Immunology and Cell Biology. 94(5). 447–457. 30 indexed citations

Mollee, Peter, Campbell Tiley, Ilona Cunningham, et al.. (2011). A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,. Blood. 118(21). 3973–3973. 3 indexed citations

10.

Brown, Ross E., et al.. (2009). Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets. European Journal of Endocrinology. 162(2). 385–390. 49 indexed citations

11.

Kenealy, Melita, John F. Seymour, Alvin Milner, et al.. (2009). The Tolerability of Combination Therapy with Thalidomide and 5-Azacitidine in Patients with Advanced Myelodysplastic Syndromes (MDS).. Blood. 114(22). 1749–1749. 2 indexed citations

12.

Fulham, Michael, Judith Trotman, Cecily Forsyth, et al.. (2006). FDG PET-CT in Primary Staging and Management of Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL): Experience in 465 Consecutive Patients.. Blood. 108(11). 2398–2398. 1 indexed citations

13.

Barnsley, Les, et al.. (2004). Clinical skills in junior medical officers: a comparison of self‐reported confidence and observed competence. Medical Education. 38(4). 358–367. 265 indexed citations

14.

Duwiejua, Mahama, et al.. (2004). A Postgraduate Clinical Pharmacy Programme in Ghana. Pharmacy Education. 4(3-4). 171–174. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact